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Abstract
Objective. Previous research suggests female and
black patients receive less optimal treatment for
their chronic pain compared with male and white
patients. Provider-related factors are hypothesized
to contribute to unequal treatment, but these factors
have not been examined extensively. This mixed
methods investigation examined the influence of
patients’ demographic characteristics on providers’
treatment decisions and providers’ awareness of
these influences on their treatment decisions.
Methods. Twenty medical trainees made treatment
decisions (opioid, antidepressant, physical therapy)
for 16 virtual patients with chronic low back pain;
patient sex and race were manipulated across
patients. Participants then indicated from a provided
list the factors that influenced their treatment deci-
sions, including patient demographics. Finally, indi-
vidual interviews were conducted to discuss the
role of patient demographics on providers’ clinical
decisions.
Results. Individual regression analyses indicated
that 30% of participants were reliably influenced by
patient sex and 15% by patient race when making
their decisions (P < 0.05 or P < 0.10). Group analy-
ses indicated that white patients received higher
antidepressant recommendations, on average, than
black patients (P < 0.05). Half of the medical trainees
demonstrated awareness of the influence of demo-
graphic characteristics on their decision making.
Participants, regardless of whether they were influ-
enced by patients’ demographics, discussed
themes related to patient sex and race; however,
participants’ discussion of patient demographics in
the interviews did not always align with their online
study results.
Conclusions. These findings suggest there is a
considerable variability in the extent to which
medical trainees are influenced by patient demo-
graphics and their awareness of these decision
making influences.
Key Words. Decision Making; Treatment Dispari-
ties; Mixed Methods; Virtual Human
Introduction
Although the majority of chronic pain patients reports
inadequate pain management, retrospective chart reviews
have found female and black patients receive less optimal
pain management compared with male and white
patients, respectively. For instance, women are more likely
than men to receive a nonspecific, somatic diagnosis and
be treated less aggressively for their pain [1,2]. Black
patients are less likely to rate their chronic pain treatment
as “very good” or “excellent” compared with white
patients [3], and black patients are less likely to receive
any analgesic medication, including opioids [4–8].
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The disparities literature consists primarily of observational
studies that lack experimental control, with only a few
experimental studies examining the influence of patient
demographics on providers’ treatment decisions. More-
over, many of the published experimental studies used
traditional “paper–pencil” vignette methods, which lack
realism. Previous experimental investigations with layper-
sons and nurses have found participants were influenced
by patient demographic characteristics when making pain
assessment ratings and treatment recommendations
[9–12]. Interestingly, findings from experimental and obser-
vational studies have been inconsistent. For instance, an
experimental study by Hirsh, George, and Robinson [10]
found nurses gave higher opioid medication ratings (i.e.,
more likely to prescribe/administer an opioid) to female
and black patients presenting with acute pain than to male
and white patients, respectively.
Although previous studies have examined patient factors
related to treatment differences, few have examined pro-
vider factors that may advance our understanding of these
differences. One provider factor that may be important in
this context is providers’ awareness of the influences on
their decision-making process, specifically the extent to
which providers are aware that they are influenced by
patient demographics when assessing and treating pain.
Studying this provider factor may help to explain some of
the inconsistencies in the literature and yield important
information on how to reduce disparities. A previous
investigation examining nurses’ level of decision-making
awareness found that although none of the nurses
reported using patient sex, race, and/or age when making
acute pain management decisions, judgment analyses
revealed between 13% and 31% of participants actually
used one of these demographic characteristics in their
decision-making process [13]. To our knowledge, no other
published studies have examined the extent to which
providers are aware of treating patients differently across
demographic groups. Addressing this gap in the dispari-
ties literature will help us understand whether providers
are knowingly making different decisions based on
patients’ sex or race or if providers are unaware of this
influence. Either finding will highlight a need for educa-
tional interventions to reduce decision-making reliance on
nonmedical factors or increase decision-making aware-
ness among medical professionals.
In the current study, we used a mixed methods approach
to examine the influence of patient sex and race on par-
ticipants’ pain treatment decisions and participants’
awareness of these influences on their decision making.
Specifically, we employed virtual human technology, lens
model methodology, and qualitative interviews to examine
medical trainees’ actual use of patient sex and race (as
indicated by individual regression analyses), self-reported
use of patient sex and race (as indicated by responses to
the “information used questionnaire”), and in-depth dis-
cussion of patient sex and race in the context of clinical
pain management (as indicated by qualitative analyses of
individual interviews). This mixed methods approach of
three data sources facilitated a more comprehensive
analysis of clinician decision making and awareness than
is possible with conventional research methods [14]. We
hypothesized that 1) a subset of trainees would be reliably
influenced by patient sex and race; 2) female and black
patients would receive less aggressive treatment than
male and white patients, respectively, except women
would receive higher antidepressant recommendations
than men; and 3) trainees would demonstrate a lack of
awareness about the influence of patient demographics
on their treatment decisions. Qualitative data were ana-
lyzed to provide a deeper understanding of providers’
perceptions of patient sex and race as influential factors in
their treatment decisions. Portions of this investigation
were presented at the 2013 American Pain Society Annual
Conference.
Methods
Procedure
This study used a mixed methods design that consisted of
both an online quantitative portion and individual qualita-
tive interviews. For the purposes of this study, we exam-
ined only those participants (20 medical trainees) who
completed both the online portion and follow-up interview.
Information on the parent investigation, which included
over 100 participants, can be found in a previous publi-
cation (see [15]). Participants were recruited from the
Indiana University School of Medicine by flyers and word
of mouth. Individuals were excluded from the parent study
if they were not a health care provider (nurse, practitioner)
or medical trainee (medical student, resident, fellow). The
online portion of the study and the qualitative interview
each took approximately 1 hour to complete, and partici-
pants received a gift card after completion of each study
portion. Study procedures were approved by our institu-
tional review board.
Quantitative Procedures
We used virtual human technology and text vignettes for
the online portion. Participants viewed 16 patient profiles;
each profile consisted of a still facial image expressing a
high level of pain (see [15] for sample images) that varied
by sex (male, female) and race (white, black). Patient
demographics were manipulated and systematically bal-
anced across the 16 profiles. To enhance realism, the
vignettes contained information about the patients’ vital
signs (e.g., blood pressure, respiration); these values
varied across patients but were always within normal
limits. The text-based vignettes presented identical infor-
mation regarding the patients’ history of chronic pain (e.g.,
pain from a back injury 1 year ago), openness to all treat-
ment options, and experiencing no other physical or
mental health symptoms (Appendix A). Depression status
was manipulated in the parent study but was held con-
stant in the current analyses (see 15). This method allowed
for a higher level of experimental control and increased the
reliability of our treatment decision data through multiple
observations.
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Participants were told that the purpose of the study was to
examine clinical decisions about pain management;
however, they were not given information about the spe-
cific aims or hypotheses. Participants were emailed
unique login credentials to access a secure study Website
(hosted on the university Web server) on their personal
computers from a quiet, private location. Participants pro-
vided informed consent and demographic information.
They then read instructions about how to complete the
treatment decision task. Participants viewed and made
treatment decisions for 16 unique patients. The order of
patient presentation was randomized. For each patient,
participants made decisions about using three common
chronic pain treatments (see Measures section below).
After rating all patients, participants selected factors they
used when making decisions for the vignettes. Finally,
participants indicated their willingness to be contacted for
a qualitative interview.
Measures
Demographic Questionnaire
Participants provided information about their sex, age,
race, and ethnicity. They also indicated their level of train-
ing (medical student or medical resident).
Treatment Decisions
For each vignette, participants were asked to rate the
likelihood that they would recommend the following three
pain treatment options: 1) opioid/narcotic pain medica-
tion; (2) antidepressant medication; and 3) physical
therapy (PT). Participants rated each treatment decision
on separate 0 (“not at all likely”) to 100 (“extremely
likely”) visual analogue scales. These treatment options
were included to better understand treatment disparities
for commonly used (i.e., opioids) and under-researched
(i.e., antidepressants, PT) treatments for chronic pain
management.
Information Used Questionnaire
Participants indicated which factors they used when
making treatment decisions for the patient vignettes. Par-
ticipants chose from a list of 10 items, such as patients’
pain history and patients’ vital signs. Specifically, we were
interested in responses to the item “patient demograph-
ics” in order to examine participants’ level of decision-
making awareness.
Qualitative Procedures
Participants willing to be contacted for a qualitative inter-
view completed the interviews 2–8 weeks after completion
of the online study. Individual, semistructured interviews
were completed in a private room on campus.
The interview guide was created after a series of meetings
between a four-member interdisciplinary research team
(clinical psychology doctoral student, clinical psychologist,
internal medicine physician, and health communications
scientist). The interview guide consisted of open-ended
questions about the influence of patient sex and race on
participants’ clinical pain management decisions. To
increase the reliability of the interview data, the same
interviewer (N.A.H.) was used for all participants. Partici-
pants and the interviewer were blinded to the results from
the online portion of the study.
Data Analyses
Quantitative Analysis
This study used a lens model design and 16 unique
patient profiles to examine two cues of interest (patient sex
and race). Lens model designs are well suited for studying
clinical decision making as they allow investigators to cal-
culate the influence of each variable of interest, or “cue,”
while holding other variables constant [16]. These other
variables consist of patient factors that were included but
not manipulated in a study (e.g., in this study, we included
patients’ facial expressions of pain in the images and their
pain histories in the text, but these were held constant
across vignettes), as well as variables that were not
included or manipulated in a study (e.g., in this study, we
did not provide information about patients’ socioeco-
nomic status [SES]). We held both types of variables con-
stant across patient vignettes and manipulated two cues
of interest (patients’ sex and race). Individual-level regres-
sion models are then used to analyze participant’s deci-
sions to determine the extent of each cue’s influence on
the participant’s decisions [16]. Our 8:1 profile-to-cue
ratio permitted each possible cue combination to be pre-
sented four times, which enhanced study power and reli-
ability of participants’ treatment ratings. This ratio also
exceeded the recommended 5:1 profile-to-cue ratio nec-
essary to achieve sufficient power for idiographic analyses
(see [17]).
All quantitative statistical analyses were performed using
PASW Statistics 18.0 (SPSS Inc., Chicago, IL, USA). We
first used descriptive statistics to summarize participants’
demographic and training level characteristics. We then
conducted both idiographic (individual-level) and nomo-
thetic (group-level) analyses to determine the influence of
patient sex and race on each participant’s pain treatment
decisions (idiographic) and the overall samples’ treatment
decisions (nomothetic). Idiographic multiple regression
analyses calculate the influence of each cue (patient sex
and race) on each participant’s separate treatment deci-
sions. To examine our first hypothesis, patient sex and
race were entered simultaneously as independent vari-
ables, and each participant’s treatment decision ratings
were entered as dependent variables in separate models.
The standardized regression coefficient (beta weight, β)
indicates the unique contribution and direction of influence
for each cue. Consistent with previous experimental
studies investigating patient sex and race, β values were
examined at both the 0.05 (referred in-text as “significantly
influenced”) and 0.10 (referred in-text as “reliably influ-
enced”) alpha level [9].
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Consistent with lens model methodology, we then exam-
ined the data using traditional group-level, or nomothetic,
analyses. Descriptive statistics were used to determine
the number of participants who were reliably influenced by
patient sex and/or race (β, P < 0.05 and P < 0.10) based
on the idiographic findings. We then squared the
semipartial correlation coefficients for each individual
regression model and summarized these values using
descriptive statistics. Participants’ average treatment
ratings for each cue (e.g., average opioid rating for black
patients) were calculated prior to conducting paired
samples t-tests to compare the treatment ratings between
male/female patients and black/white patients in the
overall sample of trainees. Cohen’s d for dependent cases
(dz) effect sizes were calculated.
We then conducted cross-tabulation analyses to examine
the concordance between participants’ decision-making
data and their questionnaire responses; these analyses
were used as an indicator of participants’ level of decision-
making awareness. We compared participants’ idio-
graphic results (coded 0 = did not reliably use patient sex
or race [P > 0.10] and 1 = reliably used patient sex or
race [P < 0.10]) with their responses to the item “patient
demographics” on the “information used questionnaire”
(coded 0 = did not endorse using patient demographics;
1 = reported using patient demographics).
Qualitative Analysis
All interviews were transcribed by a professional transcrip-
tion service. Transcripts were checked for accuracy, and
all identifying information was removed prior to review.
Data analysis followed the same analytic protocol as a
previous qualitative pain study examining health care pro-
viders [18]. This mixed methods investigation used parallel
data analysis to integrate our qualitative and quantitative
findings. This method includes collecting data separately
and using qualitative data to provide further insight into the
quantitative findings [19]. Each member of the interdisci-
plinary team read selected transcripts independently for
overall impressions. Each team member maintained a list
of themes emerging from the transcripts and met regularly
to modify, combine, add, or delete themes based on
consensus discussions and the content of subsequent
transcripts. This facilitated development of a preliminary
code list. Through an iterative process, team members
applied the preliminary code list to a transcript and met to
discuss and modify the code list based on transcripts and
discussions. When the code list was deemed stable and
consistent across reviewed transcripts, the interviewer
(N.A.H.) applied the final code list to all transcripts, includ-
ing those that had already been reviewed in the prelimi-
nary coding phases. ATLAS-TI (Atlas-ti Scientific Software
Development GmbH, Berlin, Germany) was used to facili-
tate coding. During the final stage of coding, every fourth
transcript was independently reviewed by all interdisciplin-
ary team members to ensure consensus and stability of
coding over time. Once all transcripts were coded, the
quantitative and qualitative data were reviewed to examine
patterns and variations between participants who were
reliably influenced by patient sex or race and participants
who were not reliably influenced by patient demographics
in their treatment decisions.
Power Analysis
The current lens model study was powered for idiographic
analyses (see quantitative analysis above). G*POWER was
used to conduct an a priori power analysis for nomothetic
analyses [20]. To calculate power, effect sizes were esti-
mated from a study that used a similar quantitative
research methodology and examined sex and race differ-
ences in pain management (see [10]). Effect sizes for
patient sex and race ranged from 0.59 to 0.70. The power
analysis estimated a sample size ranging from 19 to 25
participants (based on effect size of 0.70 and 0.59,
respectively; two-tailed dependent samples t-test,
α = 0.05, and power = 0.80).
This study recruited 20 participants, which falls into the
range suggested by the power analysis. In addition, lens
model studies have increased power at the group-level
due to a greater reliability of each participant’s responses
through multiple observations [17]. This investigation pre-
sented each cue combination four times (2 sex × 2 race)
to further enhance statistical power. Finally, the mixed
methods approach used in this study enhanced overall
quality and validity of our findings. [19].
Results
Twenty medical trainees (10 medical students, 10 medical
residents) completed both online and interview portions of
the study. Over half of the participants were female (65%),
and the majority was non-Hispanic (95%). Approximately
70% were white, 20% were Asian, 5% were black, and
5% were Middle Eastern.
Quantitative Results: Influence of Patient Sex
and Race
Idiographic (individual-level) and nomothetic (group-level)
results are organized by treatment type. Results of idio-
graphic regression analyses are presented in Table 1.
Descriptive data on squared semipartial correlations for
each cue are presented in Table 2. Results of nomothetic
paired samples t-test analyses are presented in Table 3.
Opioid Treatment
Sex. Results of idiographic analyses (Table 1) indicated
four participants (20%) had a significant (P < 0.05) or reli-
able (P < 0.10) regression coefficient for patient sex (β
coefficient value corresponding to patient sex). One
trainee had a statistically significant (P < 0.05) cue use for
patient sex, and three trainees had a reliable cue use for
patient sex (P < 0.10). These findings indicate that patient
sex was an influential factor in these four participants’
opioid treatment decisions. Examination of the β value
signs indicated three participants gave higher opioid treat-
ment ratings (i.e., more likely to recommend/treat with an
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opioid) to male patients, and one participant gave higher
ratings to female patients. The squared semipartial corre-
lation indicates the amount of variance patient sex
accounted for in each participant’s opioid treatment deci-
sion (Table 2). Patient sex ranged from accounting for
almost none (<1%) to over a quarter (27%) of the variance
in opioid ratings (mean amount of variance accounted for
by sex = 7%). The result of nomothetic analyses (Table 3)
Table 1 Idiographic analyses: number of trainees with reliable cue use (P < 0.10) at the individual cue
level for each treatment decision
Cue
Treatment Decision
Opioid Antidepressant
Physical
Therapy Total
Sex Male 3 1 1 4*
Female 1 0 1 2
Race White 0 0 1 1
Black 0 0 2 2
Columns represent the treatment decision. Rows represent the individual cue level. Cell values represent the number of participants
with a reliable policy for a particular treatment decision (column) weighted toward a particular individual cue (row).
* One participant had a reliable patient sex β coefficient for both opioid and antidepressant ratings (gave higher opioid and
antidepressant ratings to male patients) and is only counted once.
Table 2 Variance in treatment decisions explained by patient demographics
Treatment Decision
Sex
Mean (SD)
Range
Race
Mean (SD)
Range
R2
Mean (SD)
Range
Opioid 0.07 (0.09) 0.06 (0.05) 0.13 (0.09)
<0.01–0.27 <0.01–0.18 <0.01–0.31
Antidepressant 0.03 (0.06) 0.03 (0.04) 0.06 (0.09)
<0.01–0.21 <0.01–0.16 <0.01–0.32
Physical therapy 0.05 (0.07) 0.07 (0.08) 0.12 (0.10)
<0.01–0.29 <0.01–0.26 <0.01–0.31
Sex and race values represent squared semipartial correlations. R2 values represent the amount of variance accounted for by both
sex and race.
SD = standard deviation.
Table 3 Results of nomothetic analyses for chronic pain treatment decisions
Decision Cue Mean (SD) t dz
Opioid Sex Male 17.73 (20.9) ns <0.01
Female 17.72 (20.4)
Race White 17.13 (19.5) ns 0.28
Black 18.31 (21.5)
Antidepressant Sex Male 36.74 (16.8) ns 0.05
Female 37.12 (17.1)
Race White 38.64 (17.2) 2.159* 0.48
Black 35.22 (16.7)
Physical therapy Sex Male 75.61 (29.0) ns 0.09
Female 76.07 (29.1)
Race White 76.64 (29.7) ns 0.16
Black 75.67 (28.5)
* P < 0.05.
t is used for paired samples t-tests. dz is Cohen’s d used as effect size indices for paired samples t-tests.
ns = not significant (P > 0.05); SD = standard deviation.
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was not significant (P > 0.10, dz = < 0.01), indicating that,
at the group-level, male and female patients received
similar opioid treatment ratings.
Race. At the idiographic level, no participants were reli-
ably influenced by patient race when making opioid
ratings (P > 0.10). Squared semipartial correlations indi-
cated patient race accounted for as little as <1% and as
much as 18% (mean = 6%) of the variance in participants’
opioid treatment decisions. At the nomothetic level,
participants’ opioid treatment ratings for white and
black patients were not significantly different (P > 0.10,
dz = 0.28).
Antidepressant Treatment
Sex. One participant reliably used patient sex in
his/her treatment decision for antidepressant recommen-
dations, and this participant gave higher antide-
pressant recommendations to male patients than female
patients (P < 0.10). Patient sex accounted for almost
none (<1%) and up to 21% (mean = 3%) of the variance
in participants’ antidepressant ratings. At the group-level,
antidepressant recommendations for male and female
patients were not significantly different (P > 0.10,
dz = 0.05).
Race. At the individual-level, no participants were signifi-
cantly or reliably influenced by patient race when making
antidepressant treatment ratings, and patient race
accounted for <1% and up to 16% (mean = 3%) of the
variance in these ratings. However, when antidepressant
ratings were averaged across the entire sample and
examined at the nomothetic level, the results indicated
that white patients received significantly higher antide-
pressant ratings than black patients (t[19] = 2.159,
P < 0.05, dz = 0.48).
PT Treatment
Sex. Results of idiographic analyses indicated two partici-
pants reliably used patient sex, with one participant giving
higher PT recommendations to male patients than female
patients (P < 0.05) and the other participant showing
the opposite pattern (P < 0.10). Examining participants’
squared semipartial correlations revealed patient sex
accounted for as little as <1% to over a quarter (29%;
mean = 5%) of the variance in PT ratings. There was no
significant sex difference in average PT ratings for the
entire sample (P > 0.10, dz = 0.09).
Race. Patient race was reliably used by three participants
in their PT recommendations. Two participants gave
higher PT recommendations to black patients, and one
participant gave higher PT ratings to white patients.
Patient race also accounted for almost none (<1%) to over
a quarter (26%; mean = 7%) of the variance in PT ratings.
At the group level, PT ratings for black and white patients
were not reliably different (P > 0.10, dz = 0.16).
Influence of Patient Sex and Race
No participant was significantly or reliably influenced by
both sex and race at the idiographic level. We examined
R2 values to determine how much variance both patient
sex and race accounted for in each treatment decision
(Table 2). Collectively, patient sex and race accounted for
as much as 31% (mean = 13%) of the variance in partici-
pants’ opioid recommendations. Similarly, these two cues
accounted for as much as 32% (mean = 12%) of the
variance in participants’ antidepressant ratings and as
much as 31% (mean = 12%) of the variance in partici-
pants’ PT ratings. Across all treatments, values ranged
between accounting for almost none of the variance (<1%)
up to almost a third of the variance, further illustrating the
considerable individual variability in participants’ pain
treatment decisions.
Providers’ Level of Decision-Making Awareness
Based on idiographic analyses, a total of six participants
were significantly or reliably influenced by patient sex, and
three participants were reliably influenced by patient race
across treatment decisions (Table 1). Therefore, nine par-
ticipants (45% of sample) were reliably influenced by
patient sex or race when making treatment decisions (as
determined by β coefficient during idiographic analyses).
After making treatment recommendations, participants
indicated from a list the factors they used to make their
treatment decisions. Thirteen participants (65% of sample)
endorsed using patients’ demographics on the “informa-
tion used questionnaire” to make their treatment decisions
for the online vignettes. Thus, nine participants were actu-
ally influenced by patients’ sex or race, while 13 partici-
pants reported using patients’ demographics in their
treatment decisions.
Cross-tabulation analysis indicated that of the nine partici-
pants who were actually influenced by patient sex or race
(β, P < 0.10), six endorsed using patient demographics.
Thus, these six participants demonstrated concordance
(from a statistical perspective) between their reported and
actual use of patient demographics; this concordance
may be interpreted as demonstrating awareness of the
influence of patient demographics on decision making.
The remaining three participants did not report using
demographics, which is discordant with their actual use of
these factors and suggests they were less aware of the
influence of patient demographics on their treatment deci-
sions compared with concordant participants. Alterna-
tively, of the 11 participants who were not reliably
influenced by patient sex or race (β, P > 0.10), four did not
report using patient demographics (suggesting greater
awareness), and seven participants did report using
patient demographics in their treatment decisions (sug-
gesting a relative lack of decision-making awareness).
Overall, 10 trainees (50%) demonstrated greater aware-
ness, and 10 trainees demonstrated a relative lack of
awareness of the influence of patient demographics
on their treatment decisions. A closer examination of
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participants who demonstrated awareness indicated that
six participants were aware of being influenced by patient
demographics and four participants were aware of not
being influenced by demographics when making treat-
ment decisions. Among participants who demonstrated a
relative lack of awareness, three participants were statis-
tically influenced by patient sex or race but did not report
using patient demographics, and seven participants were
not statistically influenced but reported using these patient
factors. Based on our operational definition of awareness
(i.e., concordance between reported and actual use of
patient demographics), half of the sample demonstrated
awareness, and half of the participants demonstrated a
lack of awareness of the influence of patient demograph-
ics on their treatment decisions for chronic pain.
Qualitative Results
To better understand the influence of patient sex and race,
as well as providers’ level of decision-making awareness,
qualitative themes were examined between participants
who were reliably influenced by patient sex or race and
those who did not reliably use this patient factor (as deter-
mined by idiographic analyses). Prominent themes are
included in Table 4.
Not Reliably Influenced by Patient Sex
Participants who were not reliably influenced by patient
sex (70% of sample) reported women tend to be more
open to mental health treatments, discussed choosing
similar treatments for male and female patients, and
mentioned stereotypical occupational differences. Most
of the participants stated that women are more open to
mental health treatment options, particularly counseling
and antidepressant medication. For example, one par-
ticipant stated: “I perceive women as being more recep-
tive to counseling or to admitting that they’re depressed
as opposed to men and so I find myself suggesting . . .
antidepressants and mental health counseling maybe
more frequently to women than I do to men” (Participant
1). Most participants said they would need evidence (i.e.,
studies showing the benefits of tailoring treatments)
before they would feel comfortable tailoring based on
patient sex. However, a substantial portion of these train-
ees’ responses focused on differences in rates of
depression and fibromyalgia, which they felt warrants tai-
loring: “[T]here tends to be a higher rate of problems
with fibromyalgia and maybe depression overlying
chronic pain in women, so I would be more likely to put
them on an antidepressant” (Participant 23). Some train-
ees also mentioned stereotypical sex differences related
to occupation. For example, one participant stated: “The
women sometimes have more desk jobs . . . so you
know they can sometimes tolerate [pain] more being at
work” (Participant 11).
Reliably Influenced by Patient Sex
Five of the six participants who were reliably influenced by
patient sex reported they used the same treatments
regardless of patient sex. Only one participant in this
group expressed some awareness about the influence of
patient sex on his/her clinical decision making:
[I]t seems I do prescribe [antidepressants] more for
women just because I feel like they have more
psychological component to their pain and also
because they tend to have more diffuse pain so I’ll
have to use these drugs to kind of hit it all; whereas,
men I sometimes use more localized treatments or
I feel like they don’t have as much psychological
component to their pain. (Participant 3)
This discussion demonstrates a level of decision-making
awareness because this participant gave higher opioid
ratings to male than female patients on the online study.
Furthermore, this was the only participant within this group
to state that he/she does not “purposely try to tailor treat-
ments” based on patients’ sex but noted that “certain
genders tend to present similarly or with the same condi-
tion, so . . . that overall determines how I prescribe” (Par-
ticipant 3). However, because male and female patients in
the current study presented with the same condition (i.e.,
chronic low back pain) and symptoms, this participant’s
statement does not align with his/her quantitative data.
The remaining participants reported tailoring only if there
was strong evidence to support tailoring treatments.
Not Reliably Influenced by Patient Race
The majority of participants (85% of sample) did not reli-
ably use patient race in their treatment decisions. Overall,
participants in this group described treating white and
black patients similarly, discussed the influence of
patients’ SES on their treatment decisions, and talked
about cultural differences among the Hispanic population.
The majority of participants remarked they saw no reason
to treat patients differently based on their race.
Half of these participants stated that the patients’ SES
often influenced their treatment decisions: “It’s more of
their socioeconomic status that would make me alter the
treatment just based upon what they could feasibly get,
Table 4 Qualitative themes
Subgroup
Theme (Ranked by Most
Discussed)
Not reliably influenced
by patient sex
(N = 14)
Tailoring/individualizing treatments
Patients’ openness to treatments
Occupational differences
Reliably influenced by
patient sex (N = 6)
Tailoring/individualizing treatments
Not reliably influenced
by patient race
(N = 17)
Tailoring/individualizing treatments
Patients’ SES
Reliably influenced by
patient race (N = 3)
Tailoring/individualizing treatments
Patients’ SES
Beliefs about cultural differences
SES = socioeconomic status.
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more so than race” (Participant 6). Although participants
discussed not treating patients differently based on race,
several noted different treatment preferences among the
Hispanic population, particularly a resistance to opioid
medications. Some participants attributed this to “cultural
differences,” while another participant mentioned more
specific concerns:
I feel like the majority of my Hispanic population is
very resistant to a lot of medications. Some patients
are afraid to have narcotics in their home. They are
afraid they will get stolen, that their house will get
broken into, that they will get robbed if they know
they have narcotics. They’re also afraid of the side
effects, the sedation, the feeling loopy as they call it.
(Participant 2)
Although participants were not specifically queried about
their perceptions of Hispanic patients, nor did we include
Hispanic ethnicity in the online portion of the study, par-
ticipants demonstrated a greater willingness to discuss
differences among these patients than among black or
white patients.
Reliably Influenced by Patient Race
Three participants reliably used patients’ race when
making their treatment decisions for the online study.
Among this group, all of the trainees reported that race
was not an important factor when making treatment deci-
sions. One trainee mentioned that his/her treatment deci-
sion is more influenced by SES than race: “I don’t think it
matters so much about race as it matters as much as their
economic status. I think it probably influences us more
because our pain treatment is based on what they can
afford” (Participant 11). However, as the vignette text did
not include information on patients’ SES, this statement
does not align with this participant’s use of race in the
online study. The qualitative data suggest a relative lack of
decision-making awareness among participants in this
group.
Discussion
Female and black patients are at increased risk for sub-
optimal pain care, which may relate to providers’ being
influenced by patient sex and race when making treatment
decisions and providers’ decision-making awareness.
Using virtual human technology, lens model methodology,
and qualitative interviews, we found that almost half of the
medical trainees sampled were reliably influenced by
patient demographics when making pain treatment deci-
sions, and half of the trainees demonstrated some aware-
ness of this influence. During follow-up individual
interviews, trainees discussed treating patients similarly
regardless of patients’ sex or race; however, they per-
ceived some differences in patients’ treatment prefer-
ences. Participants influenced by patient demographics
generally did not discuss using these patient factors when
making their treatment decisions, suggesting a relative
lack of awareness about the influence of patient demo-
graphics on their clinical decisions.
Consistent with our first hypothesis, over a quarter of the
trainees (30%) were influenced by patient sex in their
treatment decisions. However, at the group level, no sig-
nificant sex differences in treatment ratings emerged.
Thus, although patient sex was not a consistently strong
predictor at the group level, individual-level analyses indi-
cated patient sex did influence a subset of trainees. These
individual differences are important to capture in empirical
studies but are typically overlooked when using a tradi-
tional group-based analyses. These individual differences
are particularly important given that women typically have
a higher prevalence of pain conditions than men [21].
During the interviews, some participants endorsed stereo-
typical beliefs about female patients, such as women have
less occupational impairment due to pain and are more
open to certain treatments (e.g., antidepressants, mental
health counseling). These views fit with evidence that pro-
viders often attribute female patients’ pain to psychologi-
cal factors, particularly when there is no observable pain
pathology, and believe that women have higher pain tol-
erances than men [22,23]. With regard to patient prefer-
ence, an investigation of total joint replacement surgery
found that women with osteoarthritis delayed surgery
longer than men due to skepticism, fears of surgery, and
distrust of surgeons, suggesting that misinformation and
bias could wrongly inform patient preference [24,25].
Additionally, Houle et al. [26] found that approximately half
of men experiencing their first episode of depression pre-
ferred psychotherapy, leading the authors to recommend
that providers ascertain patients’ preference for treatment
rather than assume preference. Medical school, residency,
and continuing medical education training should provide
evidence-based information that corrects providers’ inac-
curate beliefs about sex differences in treatment prefer-
ence and encourage discussion of preference with
patients, which may decrease sex/gender disparities and
improve pain management.
A subset of trainees (15%) was also influenced by patient
race, specifically for PT recommendations. The direction of
this effect was not always consistent, with two out of the
three trainees giving higher PT ratings to black than white
patients. Our findings conflict with published retrospective
studies (e.g., [8]), which find that compared to white
patients, black patients receive less pain management. A
possible explanation for the inconsistency is that patient
race serves as a proxy for the true operating variables that
influence providers, such as patients’ SES and access to
care. This explanation is consistent with the qualitative data
in which several participants stated patients’ SES, but not
race per se, influences their decisions. Participants also
cited issues related to patients’ insurance status and trans-
portation difficulties that influence their treatment deci-
sions. Factors such as SES and access are often
confounded with race and are not measured or controlled
for in most retrospective studies. These factors were held
constant in the current study; thus, although we attempted
to address the confounding issue, it was not possible to
specifically examine their influence on participants’ treat-
ment decisions.
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Group differences emerged with white patients receiving
higher antidepressant recommendations than black
patients. This aligns with recent findings that black
patients with depression are less likely than white
depressed patients to be treated with antidepressants
[27]. While no individual trainee was reliably influenced by
race in their antidepressant ratings, significant findings at
the group level indicate that rather than antidepressant
differences being driven by a small number of participants,
the majority of trainees gave slightly higher antidepressant
ratings to white than black patients, which summated to a
significant effect at the group level of analysis. Only one
participant discussed antidepressant medication and
patient race, stating: “Some people aren’t gonna take an
antidepressant no matter how much you push it. So you
can always offer it, but I’m sure there’s gonna be some
racial or cultural factors that would separate the patients”
(Participant 10). This group-level finding could reflect pro-
viders’ beliefs about black patients’ antidepressant pref-
erences or could be due to other factors (e.g., SES,
access to care). Future investigations should examine pro-
viders’ influences for antidepressant decision making in
order to better understand and possibly diminish this
racial disparity.
When we compared trainees’ actual (regression β values)
and self-reported (“information used questionnaire”
responses) use of patient demographics, 50% of our
sample demonstrated some awareness of their decision-
making influences, which is greater than hypothesized and
found in previous work [13]. An instructive feature of the
current study was our use of qualitative interviews to gain
a richer perspective on participants’ decision-making pro-
cesses. Interestingly, the qualitative results did not always
align with participants’ treatment or questionnaire data.
Trainees who were not reliably influenced by patient
demographics discussed using similar treatment regard-
less of the patients’ sex or race; however, this was also
true for trainees who were reliably influenced by these
patient factors. For instance, participants who were influ-
enced by patient sex typically reported they only felt com-
fortable tailoring treatments if there was supporting
evidence. While some studies suggest sex differences in
analgesic response to treatments, to date, there is no
consistent literature supporting tailoring treatments based
on patient sex alone [28,29]. Thus, although this group’s
discussion is consistent with the current clinical evidence
base, it is in contrast with their online treatment decisions,
suggesting a lack of decision-making awareness. This
nuanced understanding of participants’ decision making
was only possible through our use of mixed methods.
Similar to the discussion above, one participant acknowl-
edged using patients’ SES but not race despite the fact
that she/he did use patients’ race when making treatment
decisions for the virtual patients. This could reflect an
assumption (implicit or explicit) that nonwhite patients
have lower SES. The race–SES confounder was noted by
another participant: “[I]n this area it seems that the lower
socioeconomic status that I’ve seen in the hospital is
usually an African-American or Hispanic patient” (Partici-
pant 6). Given the small number of participants influenced
by race, this speculation should be empirically tested in
future studies. The apparent contradiction between train-
ees’ quantitative and qualitative findings could also be due
to other factors. First, the “information used questionnaire”
queried participants about their use of “patient demo-
graphics,” which may be too broad of a category; partici-
pants may be more or less aware of being influenced by a
specific patient demographic variable such as sex or race.
Secondly, because of social desirability pressures, train-
ees may be more comfortable reporting demographic
influences in anonymous online formats than discussing
these influences in face-to-face interviews [30].
Future investigations should manipulate additional patient
factors, such as SES and access to care, to determine the
extent to which these factors influence treatment deci-
sions independent of and in concert with patient sex and
race. Additionally, the interviews uncovered perceived
treatment preferences among Hispanic patients. Because
little is known about chronic pain within the Hispanic
population [31], future investigations should examine how
providers’ attitudes about Hispanic patients influence their
pain care. Such research is particularly important because
the Hispanic population is the fastest-growing demo-
graphic group in the United States, and Hispanic individu-
als are overrepresented in occupations that put workers at
an increased risk of developing chronic pain [32–35].
Finally, future investigations should examine provider
awareness of being influenced by patient sex and race,
separately, as awareness may vary between these two
patient factors.
Although this investigation had notable strengths (e.g.,
reliability of data, mixed methodology), study limitations
should be acknowledged. Analogue study designs may
not reflect real clinical scenarios, and interviews may be
limited by socially desirable responses. Group-based
analysis may have just reached adequate power with 20
participants, and qualitative data may not have reached
theoretical saturation (i.e., additional data may have
resulted in new theoretical insights or resulted in new
themes) for all qualitative analyses. However, this lens
model study used a favorable profile to cue ratio for idio-
graphic analyses, increased power with four replications
of each cue combination, and used mixed methods to
strengthen and enhance quantitative and qualitative find-
ings. Additionally, participants were asked to indicate
whether they used patients’ demographic characteristics,
rather than specifically patients’ sex and/or race, in their
treatment decisions for the quantitative study. However,
because patients’ sex and race were the only demo-
graphic factors presented and manipulated in the study, it
is unlikely that participants interpreted this question to
mean additional demographic factors (e.g., SES). Another
limitation is our recruitment of health care trainees from
one academic medical institution, which may not gener-
alize to other provider types or other parts of the country.
This investigation used a mixed methods approach to
better understand the influence of patient sex and race on
9
Race and Sex on Pain Decision MakingHollingshead et al.
288
 by guest on D
ecem
ber 22, 2016
http://painm
edicine.oxfordjournals.org/
D
ow
nloaded from
 
health care trainees’ chronic pain treatment decisions and
trainees’ awareness of these influences. Patient sex or
race was influential in a subset of participants’ decisions
for recommending opioids, antidepressants, or PT;
however, there was a considerable variability across par-
ticipants. Half of the trainees were concordant in their
reported and actual use of patients’ demographics, which
demonstrates a level of decision-making awareness and
was greater than hypothesized. Qualitative interviews pro-
vided a better understanding of the quantitative findings,
specifically with regard to trainees’ decision-making
awareness and perceptions of patient treatment prefer-
ences. Medical training programs should incorporate
evidence-based information to correct provider stereo-
types and inaccurate beliefs. Future investigations should
include additional patient (e.g., SES, Hispanic ethnicity)
and provider (e.g., attitudes) factors to examine possible
mediators and moderators of pain treatment disparities.
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Appendix A
Vignette text
The patient presents with lower back pain of approxi-
mately 1 year duration. The patient reports that the pain
began after lifting a heavy box at home. The pain is
located in the lower back and limits the patient’s ability to
perform normal daily activities. The patient expresses an
openness to any treatment recommendation and has no
absolute contraindications for the treatments listed below
(i.e., there are no medical reasons to avoid certain treat-
ments). The patient denies any other physical or mental
health symptoms. (Alternative: The patient denies any
other physical health symptoms. The patient does report
symptoms of depression over the past 6 months.)
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